| scholarly article | Q13442814 |
| P2093 | author name string | Tamir Bental | |
| Ran Kornowski | |||
| Alexander Battler | |||
| Eli I Lev | |||
| Leor Perl | |||
| Eldad Rechavia | |||
| Aviv Mager | |||
| Abid Assali | |||
| Pablo Codner | |||
| Adi Netzer | |||
| P2860 | cites work | Cardiac manifestations in antiphospholipid syndrome | Q28211851 |
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data | Q30932980 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Atherosclerosis in thrombotic primary antiphospholipid syndrome | Q34015917 | ||
| Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry | Q34156600 | ||
| Antiphospholipid syndrome; its implication in cardiovascular diseases: a review | Q34331685 | ||
| Pathogenic mechanisms mediating antiphospholipid syndrome | Q34404108 | ||
| Cardiac manifestations of the antiphospholipid syndrome | Q35533796 | ||
| Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome | Q35552883 | ||
| Systemic antiphospholipid syndrome and atherosclerosis | Q36960925 | ||
| The role of antiphospholipid syndrome in cardiovascular disease | Q37061156 | ||
| Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome | Q37318783 | ||
| Antiphospholipid antibodies: more than just a disease marker? | Q37920692 | ||
| Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease | Q41673431 | ||
| Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors | Q43174072 | ||
| Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. | Q43626449 | ||
| Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies | Q44013915 | ||
| Coagulation abnormalities in patients with precocious coronary artery thrombosis and patients failing coronary artery bypass grafting and percutaneous transcoronary angioplasty | Q44121126 | ||
| Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome | Q44734227 | ||
| Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty? | Q48021542 | ||
| Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma. | Q53657210 | ||
| Antiphospholipid syndrome | Q55891386 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 76-82 | |
| P577 | publication date | 2012-06-20 | |
| P1433 | published in | Cardiology | Q2404578 |
| P1476 | title | Long-term outcome of patients with antiphospholipid syndrome who undergo percutaneous coronary intervention | |
| P478 | volume | 122 |
| Q92912330 | Acute myocardial infarction in a young man with large left ventricular thrombus and the antiphospholipid syndrome |
| Q95584849 | Anticoagulant therapy and TEVAR in a patient with antiphospholipid syndrome presenting with pulmonary embolisms and multiple arterial embolisms due to thoracic aortic mural thrombosis |
| Q64262888 | Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form |
| Q90466950 | Chronic total occlusions of the right coronary and left anterior descending coronary arteries in a young adult patient with antiphospholipid syndrome |
| Q26750752 | Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis |
| Q40958953 | Intravascular Images of Coronary Stenosis with Multiple Channels in a Patient with Antiphospholipid Syndrome: The Optical Coherence Tomography Findings |
| Q37311800 | Neurological manifestations in patients with antiphospholipid syndrome |
| Q41830826 | Recurrent stent thrombosis in a patient with antiphospholipid syndrome and dual anti-platelet therapy non-responsiveness. |
| Q92150707 | Silent Myocardial Perfusion Abnormalities Detected by Stress Cardiovascular Magnetic Resonance in Antiphospholipid Syndrome: A Case-Control Study |
Search more.